Clinical Study
Investigation of Anti-Toxocara Antibodies in Epileptic Patients and Comparison of Two Methods: ELISA and Western Blotting
Table 3
Seroprevalence of Toxocara seropositive and seronegative in the epilepsy cases considering residency and age group.
| | | Seropositive, (%)
| Seronegative, (%)
| Total
| Statistic
|
| | Residence | | | | | | Rural | 7 (70.0) | 60 (80.0) | 67 | Not significant | | Urban | 3 (30.0) | 15 (20.0) | 18 | | Age group (years) | | | | | | <20 | 6 (60.0) | 36 (48.0) | 42 | Not significant | | 20–39 | 3 (30.0) | 25 (33.3) | 28 | | 40–59 | 1 (10.1) | 11 (14.7) | 12 | | ≥60 | 0 (0.0) | 3 (4.0) | 3 |
|
|
